Improved systemic safety and risk–benefit ratio of topical 0.1% timolol hydrogel compared with 0.5% timolol aqueous solution in the treatment of glaucoma-Reference-Cited by-同舟云学术

Improved systemic safety and risk–benefit ratio of topical 0.1% timolol hydrogel compared with 0.5% timolol aqueous solution in the treatment of glaucoma

Published:2006-04-21 Issue:11 Volume:244 Page:1491-1496
ISSN:0721-832X
Container-title:Graefe's Archive for Clinical and Experimental Ophthalmology
language:en
Short-container-title:Graefe's Arch Clin Exp Ophthalmo

Author:

Uusitalo Hannu,Kähönen Mika,Ropo Auli,Mäenpää Jukka,Bjärnhall Gunilla,Hedenström Hans,Turjanmaa Väinö

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Sensory Systems,Ophthalmology

Link

http://link.springer.com/content/pdf/10.1007/s00417-006-0328-0.pdf

Reference15 articles.

1. Boger WP III (1979) Timolol: short term “escape” and long term “drift”. Ann Ophthalmol 11:1239–1242

2. Brooks AM, Gillies WE (1992) Ocular beta-blockers in glaucoma management. Clinical pharmacological aspects. Drugs Aging 2:208–221

3. Dickstein K, Aarsland T (1996) Comparison of the effects of aqueous and gellan ophthalmic timolol on peak exercise performance in middle-aged men. Am J Ophthalmol 121:367–371

4. Dickstein K, Hapnes R, Aarsland T (2001) Comparison of aqueous and gellan ophthalmic timolol with placebo on the 24-hour heart rate response in patients on treatment for glaucoma. Am J Ophthalmol 132:626–631

5. Everitt DE, Avorn J (1990) Systemic effects of medications used to treat glaucoma. Ann Int Med 112:120–125

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Use of Timolol for Wound Healing—A Review;Current Dermatology Reports;2024-02-22

2. Severe systemic adverse reactions to ophthalmic timolol in a CYP2D6 homozygous *4 allele carrier: a case report;Pharmacogenomics;2023-09-15

3. Development and In-vitro Evaluation of Dexamethasone Enriched Nanoemulsion for Ophthalmic Indication;Drug Delivery Letters;2023-09

4. Sustained release ocular drug delivery systems for glaucoma therapy;Expert Opinion on Drug Delivery;2023-06-12

5. Comprehensive Pharmacology: Glaucoma;Reference Module in Biomedical Sciences;2021